Clinical
Qualified
All solutions undergo a comprehensive qualification process encompassing regulatory compliance, technological, clinical, and algorithmic performance. This ensures clear and transparent communication of each solution's maturity, efficacy, safety, and bias mitigation to potential end-users.
Medication decisions can be complex. Clinicians must review pharmacogenomic results, drug interactions, and patient-specific risk factors across multiple sources. This process can be time-consuming and difficult to standardize.
This pharmacogenomic solution helps clinicians interpret genetic test results and evaluate medication-related risks in a single workflow. The platform combines drug-gene, drug-drug, and drug-condition interaction screening with evidence-linked guidance from trusted clinical sources. Clinicians receive traceable recommendations, interaction summaries, and supporting references in one report.
Learn more about the Pharmacogenomic Screening solution by connecting with Mayo Clinic Platform experts